Key facts
- Arcus Biosciences chief accounting officer sold 2,675 shares.
- The value of the sold shares was $66,023.
- The transaction took place on December 14, 2023.
Insider selling can sometimes be interpreted as a signal of a company executive's confidence in the company's future prospects. However, such sales can also be for personal financial planning or diversification reasons, and do not necessarily indicate a negative outlook.
